JP2015518006A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015518006A5 JP2015518006A5 JP2015514242A JP2015514242A JP2015518006A5 JP 2015518006 A5 JP2015518006 A5 JP 2015518006A5 JP 2015514242 A JP2015514242 A JP 2015514242A JP 2015514242 A JP2015514242 A JP 2015514242A JP 2015518006 A5 JP2015518006 A5 JP 2015518006A5
- Authority
- JP
- Japan
- Prior art keywords
- human
- allergic condition
- composition
- hydrochloride
- performed via
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261651741P | 2012-05-25 | 2012-05-25 | |
| US61/651,741 | 2012-05-25 | ||
| PCT/US2013/042925 WO2013177594A2 (en) | 2012-05-25 | 2013-05-28 | Xylitol-based anti-mucosal compositions and related methods and compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015518006A JP2015518006A (ja) | 2015-06-25 |
| JP2015518006A5 true JP2015518006A5 (https=) | 2017-03-23 |
Family
ID=49621806
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015514242A Pending JP2015518006A (ja) | 2012-05-25 | 2013-05-28 | キシリトール系の抗粘膜組成物及び関連する方法並びに組成物 |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US8709508B2 (https=) |
| EP (1) | EP2854781A4 (https=) |
| JP (1) | JP2015518006A (https=) |
| KR (1) | KR20150011807A (https=) |
| CN (1) | CN104334164A (https=) |
| AU (1) | AU2013266067B2 (https=) |
| BR (1) | BR112014029442A2 (https=) |
| CA (1) | CA2870158C (https=) |
| IL (1) | IL235875A (https=) |
| MX (1) | MX2014013998A (https=) |
| RU (1) | RU2607892C2 (https=) |
| WO (1) | WO2013177594A2 (https=) |
| ZA (1) | ZA201408594B (https=) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9925282B2 (en) | 2009-01-29 | 2018-03-27 | The General Hospital Corporation | Cromolyn derivatives and related methods of imaging and treatment |
| US20120225918A1 (en) | 2011-03-03 | 2012-09-06 | Voom, Llc | Compositions and Methods for Non-Surgical Treatment of Ptosis |
| AU2013266067B2 (en) | 2012-05-25 | 2016-10-06 | Xlear, Inc. | Xylitol-based anti-mucosal compositions and related methods and compositions |
| US10058530B2 (en) | 2012-10-25 | 2018-08-28 | The General Hospital Corporation | Combination therapies for the treatment of Alzheimer's disease and related disorders |
| CA2889446C (en) | 2012-10-25 | 2021-05-11 | The General Hospital Corporation | Combination therapies for the treatment of alzheimer's disease and related disorders |
| MX365950B (es) | 2013-03-13 | 2019-06-19 | Flatley Discovery Lab Llc | Compuestos de piridazinona y metodos para el tratamiento de la fibrosis quistica. |
| US10525005B2 (en) | 2013-05-23 | 2020-01-07 | The General Hospital Corporation | Cromolyn compositions and methods thereof |
| AU2014340182B2 (en) | 2013-10-22 | 2019-05-23 | The General Hospital Corporation | Cromolyn derivatives and related methods of imaging and treatment |
| PL3104854T3 (pl) | 2014-02-10 | 2020-11-30 | Respivant Sciences Gmbh | Stabilizatory komórek tucznych do leczenia choroby płuc |
| WO2015120389A1 (en) | 2014-02-10 | 2015-08-13 | Patara Pharma, LLC | Mast cell stabilizers treatment for systemic disorders |
| US10265296B2 (en) | 2015-08-07 | 2019-04-23 | Respivant Sciences Gmbh | Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders |
| WO2017027387A1 (en) | 2015-08-07 | 2017-02-16 | Patara Pharma, LLC | Methods for the treatment of mast cell related disorders with mast cell stabilizers |
| US20180008598A1 (en) * | 2016-07-07 | 2018-01-11 | Xlear, Inc. | Antibacterial nasal compositions and related methods |
| CA3033079A1 (en) | 2016-08-31 | 2018-03-08 | The General Hospital Corporation | Macrophages/microglia in neuro-inflammation associated with neurodegenerative diseases |
| EP3506893A4 (en) | 2016-08-31 | 2020-01-22 | Respivant Sciences GmbH | CROMOLYN COMPOSITIONS FOR THE TREATMENT OF CHRONIC COUGH DUE TO IDIOPATHIC PULMONAL FIBROSIS |
| JP2019531308A (ja) | 2016-10-07 | 2019-10-31 | レシュピファント サイエンシス ゲゼルシャフト ミット ベシュレンクター ハフトゥングＲｅｓｐｉｖａｎｔ Ｓｃｉｅｎｃｅｓ Ｇｍｂｈ | 肺線維症の治療のためのクロモリン組成物 |
| JP7202376B2 (ja) | 2017-07-20 | 2023-01-11 | エーゼットセラピーズ， インコーポレイテッド | クロモリンナトリウムおよびイブプロフェンの粉末製剤 |
| KR20210071943A (ko) | 2018-07-02 | 2021-06-16 | 더 제너럴 하스피탈 코포레이션 | 크로몰린 소듐 및 α-락토스의 분말화된 제형 |
| WO2020123449A1 (en) | 2018-12-10 | 2020-06-18 | The General Hospital Corporation | Cromolyn esters and uses thereof |
| US10814001B1 (en) | 2019-05-06 | 2020-10-27 | Rvl Pharmaceuticals, Inc. | Oxymetazoline compositions |
| EP4132507A4 (en) | 2020-04-06 | 2024-05-15 | The General Hospital Corporation | Methods of treatment of coronavirus-induced inflammation conditions |
| WO2021216869A1 (en) | 2020-04-24 | 2021-10-28 | Joseph Scivoletto | Nasal spray composition |
| WO2022140795A2 (en) * | 2020-12-23 | 2022-06-30 | Spotlight Therapeutics | Nucleic acid binding protein formulations and uses thereof |
| CN116211884B (zh) * | 2023-02-16 | 2024-05-17 | 海孵(海南自贸区)医疗科技有限责任公司 | 一种鼻腔喷雾剂及其制备方法 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01172324A (ja) * | 1987-12-15 | 1989-07-07 | Armour Internatl Co | コレスチラミン組成物及びその製造法 |
| JP2824863B2 (ja) * | 1989-07-12 | 1998-11-18 | エーザイ株式会社 | α▲下１▼―ブロッカー点眼剤 |
| JP2001524108A (ja) * | 1997-04-30 | 2001-11-27 | ワーナー−ランバート・カンパニー | 局所経鼻抗炎症組成物 |
| US6054143A (en) * | 1998-03-24 | 2000-04-25 | Jones; Alonzo H. | Xylitol delivery |
| US6599883B1 (en) | 1998-10-30 | 2003-07-29 | Nastech Pharmaceutical Company, Inc. | Nasal delivery of xylitol |
| DE19947234A1 (de) * | 1999-09-30 | 2001-04-05 | Asta Medica Ag | Neue Kombination von Loteprednol und Antihistaminika |
| US20040235807A1 (en) * | 2003-05-21 | 2004-11-25 | Weinrich Karl P. | Formulations including a topical decongestant and a topical corticosteroid suitable for nasal administration and method for treating obstructive sleep apnea |
| AU2004264974A1 (en) * | 2003-08-15 | 2005-02-24 | Arius Two, Inc. | Adhesive bioerodible transmucosal drug delivery system |
| US20060034947A1 (en) | 2004-06-02 | 2006-02-16 | Burr James B | Erythritol compositions for nasopharynx cleansing |
| DK2377557T3 (en) * | 2004-11-24 | 2017-02-06 | Meda Pharmaceuticals Inc | Compositions comprising azelastine and methods for its use |
| GB0426068D0 (en) * | 2004-11-29 | 2004-12-29 | Passion For Life Healthcare Lt | Composition with bacteria blocking action |
| US20060120967A1 (en) * | 2004-12-07 | 2006-06-08 | Qpharma, Llc | Solution forms of cyclodextrins for nasal or throat delivery of essential oils |
| US20060275223A1 (en) | 2005-06-02 | 2006-12-07 | Burr James B | Erythritol compositions for teeth and gums |
| US20070286813A1 (en) * | 2006-06-09 | 2007-12-13 | Toutounghi Camille | Nasal formulation |
| US20070286812A1 (en) * | 2006-06-09 | 2007-12-13 | Toutounghi Camille | Nasal formulation |
| US20100099650A1 (en) * | 2006-10-10 | 2010-04-22 | Knauer Kent A | Nasal spray composition and method for treating rhinitis, sinusitis or both |
| US8658225B2 (en) * | 2008-12-31 | 2014-02-25 | Znova, Llc | Herbal-based nasal solution and method of use thereof |
| DE202010012255U1 (de) * | 2010-09-07 | 2010-11-18 | Krewel Meuselbach Gmbh | Nasenspray |
| AU2013266067B2 (en) | 2012-05-25 | 2016-10-06 | Xlear, Inc. | Xylitol-based anti-mucosal compositions and related methods and compositions |
-
2013
- 2013-05-28 AU AU2013266067A patent/AU2013266067B2/en not_active Ceased
- 2013-05-28 CA CA2870158A patent/CA2870158C/en active Active
- 2013-05-28 BR BR112014029442A patent/BR112014029442A2/pt not_active Application Discontinuation
- 2013-05-28 CN CN201380027507.XA patent/CN104334164A/zh active Pending
- 2013-05-28 MX MX2014013998A patent/MX2014013998A/es not_active Application Discontinuation
- 2013-05-28 JP JP2015514242A patent/JP2015518006A/ja active Pending
- 2013-05-28 EP EP13793355.2A patent/EP2854781A4/en not_active Ceased
- 2013-05-28 RU RU2014147090A patent/RU2607892C2/ru active
- 2013-05-28 KR KR20147031835A patent/KR20150011807A/ko not_active Ceased
- 2013-05-28 US US13/903,860 patent/US8709508B2/en active Active
- 2013-05-28 WO PCT/US2013/042925 patent/WO2013177594A2/en not_active Ceased
-
2014
- 2014-04-22 US US14/258,993 patent/US9011941B2/en active Active
- 2014-11-21 ZA ZA2014/08594A patent/ZA201408594B/en unknown
- 2014-11-24 IL IL235875A patent/IL235875A/en active IP Right Grant
-
2015
- 2015-01-27 US US14/606,888 patent/US20150140137A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015518006A5 (https=) | ||
| CA2870158C (en) | Xylitol-based anti-mucosal compositions and related methods and compositions | |
| BR112015029491A2 (pt) | derivados de imidazopirrolidinona e seu uso no tratamento de doença | |
| EA201270221A1 (ru) | Лечение болезни крона с применением лаквинимода | |
| BR112015018252A2 (pt) | composição farmacêutica aquosa de dose fixa estável para administração nasal para um ser humano, composição de suspensão aquosa farmacêutica de dose fixa estável para administração nasal para um ser humano, suspensão estável adequada para administração nasal a um ser humano, método para tratar rinite em um ser humano necessitando do mesmo, uso da composição farmacêutica para administração nasal, método para liberar uma composição farmacêutica e kit | |
| MX2015015589A (es) | Composiciones y metodos para el suministro de agentes activos hidrófobos. | |
| HRP20171739T1 (hr) | Postupci i kompozicije za liječenje simptoma povezanih s posttraumatskim stresnim poremećajem korištenjem ciklobenzaprina | |
| JP2013534527A5 (https=) | ||
| BRPI0806392A8 (pt) | uso de aclidínio, aclidínio, método de tratamento ou prevenção e composição farmacêutica | |
| CO6400184A2 (es) | Formulaciones galénicas de compuestos orgánicos | |
| EA201400002A1 (ru) | Способы лечения заболеваний сетчатки | |
| HRP20151381T1 (hr) | Nazalni sprej | |
| WO2010024956A3 (en) | Antihistamine and antihistamine-like nasal application, products, and method | |
| HRP20230809T1 (hr) | Liječenje alzheimerove bolesti u određenoj populaciji bolesnika | |
| JP2016525548A5 (https=) | ||
| ATE507818T1 (de) | Orale verabreichung eines calcitonins | |
| BR112013027010A2 (pt) | método de produzir substâncias com gás supersaturado, dispositivo para sua entrega trasdérmica, e seus usos | |
| DOP2015000071A (es) | Fármaco combinado que comprende gemigliptina y metformina, y método para su preparación | |
| CL2015002627A1 (es) | Composiciones para el uso en el tratamiento de trastornos oculares que usan dipiridamol | |
| BR112014005538A2 (pt) | composições aquosas compreendendo arbecacina | |
| JP2016502991A5 (https=) | ||
| BR112015018200A2 (pt) | composição mastigável para administração oral e processo para preparar a mesma | |
| JP2014530847A5 (https=) | ||
| BR112015030341A2 (pt) | formulações de nanoparticulado e processo para prepará-las, composição farmacêutica e uso de composto ou seu sal farmaceuticamente aceitável e estabilizante de superfície | |
| MX380536B (es) | Composicion y metodo para tratar la enfermedad de chagas. |